查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲類器官服務市場報告（2021-2031）範圍、細分、動態和競爭分析
市場調查報告書
商品編碼
1843396

歐洲類器官服務市場報告（2021-2031）範圍、細分、動態和競爭分析

Europe Organoids Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 136 Pages | 訂單完成後即時交付

價格

預計歐洲類器官服務市場將大幅成長，到 2031 年將達到約 50.1603 億美元，高於 2024 年的 12.3351 億美元。這一成長代表著 2024 年至 2031 年的年複合成長率(CAGR) 為 22.2%。

執行摘要和市場分析

歐洲類器官服務市場主要分為幾個主要區域，包括德國、法國、英國、西班牙、義大利和歐洲其他地區。該市場的成長受到多種因素的推動，包括組織工程和器官移植需求的不斷成長，類器官在疾病建模、基因突變研究和腫瘤建模中的應用日益增多，以及針對類器官的研發活動激增。此外，公共和私營部門的資金和投資增加預計將在不久的將來為市場創造巨大的機會。

市場區隔分析

歐洲類器官服務市場可根據類型、應用和來源進行細分：

  • 依類型：市場分為各種器官類型，包括腸、肝、胃、胰臟、肺、腦、腎等。預計到2024年，腸道器官將佔據最大的市場佔有率。
  • 依應用：類器官的應用分為發育生物學疾病、傳染病病理學、再生醫學、藥物毒性和療效測試、藥物發現和個人化醫療等。預計發育生物學疾病領域將在2024年佔據市場主導地位。
  • 依來源：市場也依類器官的來源細分，包括多能幹細胞和器官特異性成體幹細胞。預計到2024年，多能幹細胞領域將佔據更大的市場佔有率。

市場展望

歐洲對個人化醫療日益成長的需求是影響類器官技術發展和應用的重要因素，尤其是在腫瘤學和遺傳性疾病領域。倫敦國王學院與葛蘭素史克公司之間的一項重要合作體現了這一趨勢，研究人員正在開發源自患者的肺癌類器官，以預測復發並確定有效的治療組合。這些類器官旨在反映每位患者癌症中發現的獨特基因突變，促進個人化治療方案的選擇。此外，歐洲藥品管理局 (EMA) 已經認知到類器官技術在精準醫療中的重要性，並透過其自適應途徑計劃支持類器官等創新方法，以加快新療法的核准，從而彌合研究與臨床應用之間的差距。

國家洞察

歐洲類器官服務市場主要包括英國、法國、德國、西班牙、義大利及歐洲其他地區。預計德國將在2024年佔據最大市場佔有率。

受組織工程和器官移植技術的進步以及持續進行的類器官研究的推動，德國對類器官服務的需求日益成長。德國蓬勃發展的研究部門正在推動新型類器官生成方法的出現，增強其在人類疾病建模中的作用，並開闢新的研究途徑。得益於高品質的產品，德國生物技術產業展現出巨大的成長潛力。德國擁有眾多專門從事類器官服務的公司，例如位於柏林的馬克斯·德爾布呂克中心，該中心提供類器官衍生和表徵的平台服務。

公司簡介

歐洲類器官服務市場的主要參與者包括 CUSABIO TECHNOLOGY LLC、Cyprio、Eurofins Scientific SE、HUB Organoids BV（Hubrecht Organoid Technology）、InnoSer、InSphero、LABTOO、Molecular Devices, LLC、Oncodesign Services 和 Sino Biological Inc. 等。這些公司正在採用各種策略，包括擴張、產品創新和併購，以增強其產品服務並提升其市場佔有率。

目錄

第1章：簡介

第 2 章：執行摘要

  • 關鍵見解

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第4章：歐洲類器官服務市場格局

  • PEST分析

第5章：歐洲類器官服務市場－主要市場動態

  • 歐洲類器官服務市場－關鍵市場動態
  • 市場促進因素
    • 創新藥物篩選服務需求不斷成長
    • 個人化藥物的普及度激增
  • 市場限制
    • 缺乏熟練的專業人員
  • 市場機會
    • 增加關鍵發展
  • 未來趨勢
    • 人工智慧的融合
  • 促進因素和限制因素的影響：

第6章：歐洲類器官服務市場－分析

  • 2021-2031年歐洲類器官服務市場收入
  • 歐洲類器官服務市場預測分析

第7章：歐洲類器官服務市場分析－依類型

  • 腸
  • 肝
  • 胃
  • 胰臟
  • 肺
  • 腦
  • 腎
  • 其他

第8章：歐洲類器官服務市場分析－依應用

  • 發育生物學疾病
  • 傳染病病理學
  • 再生醫學
  • 藥物毒性和療效測試
  • 藥物研發與個人化醫療
  • 其他

第9章：歐洲類器官服務市場分析－依來源

  • 多能幹細胞
  • 器官特異性成體幹細胞

第 10 章：歐洲類器官服務市場 - 國家分析

  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區

第 11 章：產業格局

  • 概述
  • 類器官服務市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 12 章：公司簡介

  • Sino Biological Inc.
  • Eurofins Scientific SE
  • Molecular Devices, LLC.
  • InSphero
  • Cyprio
  • InnoSer
  • LABTOO
  • CUSABIO TECHNOLOGY LLC
  • Oncodesign Services
  • HUB Organoids B.V. (Hubrecht Organoid Technology)

第 13 章：附錄

Product Code: BMIRE00032024

The Europe organoids services market is projected to grow significantly, reaching approximately US$ 5,016.03 million by 2031, up from US$ 1,233.51 million in 2024. This growth represents a compound annual growth rate (CAGR) of 22.2% from 2024 to 2031.

Executive Summary and Market Analysis

The market for organoid services in Europe is divided into several key regions, including Germany, France, the UK, Spain, Italy, and the Rest of Europe. The growth in this market is driven by several factors, including the increasing demand for tissue engineering and organ transplantation, the rising use of organoids in disease modeling, gene mutation studies, and tumor modeling, as well as a surge in research and development focused on organoids. Additionally, enhanced funding and investments from both public and private sectors are expected to create substantial opportunities in the market in the near future.

Market Segmentation Analysis

The Europe organoids services market can be segmented based on type, application, and source:

  • By Type: The market is categorized into various organ types, including intestine, liver, stomach, pancreas, lung, brain, kidney, and others. In 2024, the intestine segment is anticipated to hold the largest market share.
  • By Application: The applications of organoids are segmented into developmental biology disease, pathology of infectious diseases, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, among others. The developmental biology disease segment is expected to dominate the market in 2024.
  • By Source: The market is also segmented by the source of organoids, which includes pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment is projected to have a larger market share in 2024.

Market Outlook

The increasing demand for personalized medicine in Europe is a significant factor influencing the advancement and application of organoid technologies, particularly in oncology and genetic disorders. A notable collaboration between King's College London and GSK exemplifies this trend, where researchers are developing patient-derived lung cancer organoids to predict relapse and identify effective treatment combinations. These organoids are designed to reflect the unique genetic mutations found in each patient's cancer, facilitating tailored therapy selection. Furthermore, the European Medicines Agency (EMA) has recognized the importance of organoid technology in precision medicine, supporting innovative methods like organoids through its adaptive pathways initiative to expedite the approval of new therapies, thus bridging the gap between research and clinical application.

Country Insights

The Europe organoids services market includes key countries such as the UK, France, Germany, Spain, Italy, and the Rest of Europe. Germany is expected to hold the largest market share in 2024.

The demand for organoid services in Germany is on the rise, driven by advancements in tissue engineering and organ transplantation, along with ongoing organoid research. The country's robust research sector is leading to the emergence of new organoid generation methods, enhancing their role in human disease modeling and opening new research avenues. Germany's biotechnology industry shows significant growth potential, supported by the high quality of its products. Numerous companies specializing in organoid services operate within the country, such as the Max Delbruck Center in Berlin, which provides platform services for organoid derivation and characterization.

Company Profiles

Key players in the Europe organoids services market include CUSABIO TECHNOLOGY LLC, Cyprio, Eurofins Scientific SE, HUB Organoids B.V. (Hubrecht Organoid Technology), InnoSer, InSphero, LABTOO, Molecular Devices, LLC, Oncodesign Services, and Sino Biological Inc., among others. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their offerings and increase their market presence.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Organoids Services Market Landscape

  • 4.1 PEST Analysis

5. Europe Organoids Services Market - Key Market Dynamics

  • 5.1 Europe Organoids Services Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Demand for Innovative Drug Screening Services
    • 5.2.2 Surge in Popularity of Personalized Drugs
  • 5.3 Market Restraints
    • 5.3.1 Dearth of Skilled Professionals
  • 5.4 Market Opportunities
    • 5.4.1 Increasing Key Developments
  • 5.5 Future Trends
    • 5.5.1 Integration of Artificial Intelligence
  • 5.6 Impact of Drivers and Restraints:

6. Europe Organoids Services Market - Analysis

  • 6.1 Europe Organoids Services Market Revenue (US$ Million), 2021-2031
  • 6.2 Europe Organoids Services Market Forecast Analysis

7. Europe Organoids Services Market Analysis - by Type

  • 7.1 Intestine
    • 7.1.1 Overview
    • 7.1.2 Intestine: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Liver
    • 7.2.1 Overview
    • 7.2.2 Liver: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Stomach
    • 7.3.1 Overview
    • 7.3.2 Stomach: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Pancreas
    • 7.4.1 Overview
    • 7.4.2 Pancreas: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.5 Lung
    • 7.5.1 Overview
    • 7.5.2 Lung: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.6 Brain
    • 7.6.1 Overview
    • 7.6.2 Brain: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.7 Kidney
    • 7.7.1 Overview
    • 7.7.2 Kidney: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Organoids Services Market Analysis - by Application

  • 8.1 Developmental Biology Disease
    • 8.1.1 Overview
    • 8.1.2 Developmental Biology Disease: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Pathology of Infectious Disease
    • 8.2.1 Overview
    • 8.2.2 Pathology of Infectious Disease: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Regenerative Medicine
    • 8.3.1 Overview
    • 8.3.2 Regenerative Medicine: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Drug Toxicity and Efficacy Testing
    • 8.4.1 Overview
    • 8.4.2 Drug Toxicity and Efficacy Testing: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.5 Drug Discovery and Personalized Medicine
    • 8.5.1 Overview
    • 8.5.2 Drug Discovery and Personalized Medicine: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Organoids Services Market Analysis - by Source

  • 9.1 Pluripotent Stem Cells
    • 9.1.1 Overview
    • 9.1.2 Pluripotent Stem Cells: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Organ Specific Adult Stem Cell
    • 9.2.1 Overview
    • 9.2.2 Organ Specific Adult Stem Cell: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Organoids Services Market - Country Analysis

  • 10.1 Europe
    • 10.1.1 Europe Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 Europe Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.2 Germany: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.2.1 Germany: Europe Organoids Services Market Share - by Type
        • 10.1.1.2.2 Germany: Europe Organoids Services Market Share - by Application
        • 10.1.1.2.3 Germany: Europe Organoids Services Market Share - by Source
      • 10.1.1.3 United Kingdom: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.3.1 United Kingdom: Europe Organoids Services Market Share - by Type
        • 10.1.1.3.2 United Kingdom: Europe Organoids Services Market Share - by Application
        • 10.1.1.3.3 United Kingdom: Europe Organoids Services Market Share - by Source
      • 10.1.1.4 France: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.4.1 France: Europe Organoids Services Market Share - by Type
        • 10.1.1.4.2 France: Europe Organoids Services Market Share - by Application
        • 10.1.1.4.3 France: Europe Organoids Services Market Share - by Source
      • 10.1.1.5 Italy: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.5.1 Italy: Europe Organoids Services Market Share - by Type
        • 10.1.1.5.2 Italy: Europe Organoids Services Market Share - by Application
        • 10.1.1.5.3 Italy: Europe Organoids Services Market Share - by Source
      • 10.1.1.6 Spain: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.6.1 Spain: Europe Organoids Services Market Share - by Type
        • 10.1.1.6.2 Spain: Europe Organoids Services Market Share - by Application
        • 10.1.1.6.3 Spain: Europe Organoids Services Market Share - by Source
      • 10.1.1.7 Rest of Europe: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.7.1 Rest of Europe: Europe Organoids Services Market Share - by Type
        • 10.1.1.7.2 Rest of Europe: Europe Organoids Services Market Share - by Application
        • 10.1.1.7.3 Rest of Europe: Europe Organoids Services Market Share - by Source

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Organoids Services Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Sino Biological Inc.
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Eurofins Scientific SE
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Molecular Devices, LLC.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 InSphero
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Cyprio
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 InnoSer
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 LABTOO
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 CUSABIO TECHNOLOGY LLC
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Oncodesign Services
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 HUB Organoids B.V. (Hubrecht Organoid Technology)
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Organoids Services Market Segmentation
  • Table 2. Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
  • Table 4. Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 5. Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Source
  • Table 6. Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 7. Germany: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 8. Germany: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 9. Germany: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 10. United Kingdom: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 11. United Kingdom: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 12. United Kingdom: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 13. France: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 14. France: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 15. France: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 16. Italy: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 17. Italy: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 18. Italy: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 19. Spain: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 20. Spain: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 21. Spain: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 22. Rest of Europe: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
  • Table 23. Rest of Europe: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 24. Rest of Europe: Europe Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
  • Table 25. Recent Organic Growth Strategies in Organoids Services Market
  • Table 26. Recent Inorganic Growth Strategies in the Organoids Services Market
  • Table 27. Glossary of Terms, Organoids Services Market

List Of Figures

  • Figure 1. Europe Organoids Services Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Organoids Services Market Revenue (US$ Million), 2021-2031
  • Figure 5. Europe Organoids Services Market Share (%) - by Type (2023 and 2031)
  • Figure 6. Intestine: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Liver: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Stomach: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Pancreas: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Lung: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Brain: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Kidney: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Others: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Europe Organoids Services Market Share (%) - by Application (2023 and 2031)
  • Figure 15. Developmental Biology Disease: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Pathology of Infectious Disease: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Regenerative Medicine: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Drug Toxicity and Efficacy Testing: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Drug Discovery and Personalized Medicine: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Others: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Europe Organoids Services Market Share (%) - by Source (2023 and 2031)
  • Figure 22. Pluripotent Stem Cells: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 23. Organ Specific Adult Stem Cell: Europe Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 24. Europe Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 25. Germany: Europe Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. United Kingdom: Europe Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 27. France: Europe Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 28. Italy: Europe Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 29. Spain: Europe Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 30. Rest of Europe: Europe Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 31. Growth Strategies in Organoids Services Market